questionsmedicales.fr
Composés chimiques organiques
Hydrocarbures
Hydrocarbures cycliques
Hydrocarbures aromatiques
Dérivés du benzène
Phénols
Catéchols
Catécholamines
Catécholamines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Catécholamines
Diagnostic médical
Tests de laboratoire
Catécholamines
Imagerie médicale
Tumeurs surrénaliennes
Tests génétiques
Syndromes héréditaires
Symptômes
5
Palpitations
Fréquence cardiaque
Maux de tête
Hypertension
Troubles de l'humeur
Anxiété
Nausées
Troubles gastro-intestinaux
Prévention
5
Prévention
Gestion du stress
Mode de vie sain
Alimentation équilibrée
Stress
Techniques de relaxation
Examens médicaux
Détection précoce
Éducation à la santé
Symptômes
Traitements
5
Traitement médical
Chirurgie
Bêta-bloquants
Inhibiteurs de la monoamine oxydase
Chirurgie
Phéochromocytome
Médecine alternative
Gestion du stress
Suivi médical
Pression artérielle
Complications
5
Complications
Hypertension
Diabète
Régulation de la glycémie
Troubles psychologiques
Anxiété
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Tabagisme
Système cardiovasculaire
Stress émotionnel
Production de catécholamines
Maladies endocriniennes
Production de catécholamines
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Catécholamines : Questions médicales les plus fréquentes",
"headline": "Catécholamines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Catécholamines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-14",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Catécholamines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Catéchols",
"url": "https://questionsmedicales.fr/mesh/D002396",
"about": {
"@type": "MedicalCondition",
"name": "Catéchols",
"code": {
"@type": "MedicalCode",
"code": "D002396",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Carbidopa",
"alternateName": "Carbidopa",
"url": "https://questionsmedicales.fr/mesh/D002230",
"about": {
"@type": "MedicalCondition",
"name": "Carbidopa",
"code": {
"@type": "MedicalCode",
"code": "D002230",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.200.538.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dobutamine",
"alternateName": "Dobutamine",
"url": "https://questionsmedicales.fr/mesh/D004280",
"about": {
"@type": "MedicalCondition",
"name": "Dobutamine",
"code": {
"@type": "MedicalCode",
"code": "D004280",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.220"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dopamine",
"alternateName": "Dopamine",
"url": "https://questionsmedicales.fr/mesh/D004298",
"about": {
"@type": "MedicalCondition",
"name": "Dopamine",
"code": {
"@type": "MedicalCode",
"code": "D004298",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.342"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hydroxydopamines",
"alternateName": "Hydroxydopamines",
"url": "https://questionsmedicales.fr/mesh/D006892",
"about": {
"@type": "MedicalCondition",
"name": "Hydroxydopamines",
"code": {
"@type": "MedicalCode",
"code": "D006892",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.342.478"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Oxidopamine",
"alternateName": "Oxidopamine",
"url": "https://questionsmedicales.fr/mesh/D016627",
"about": {
"@type": "MedicalCondition",
"name": "Oxidopamine",
"code": {
"@type": "MedicalCode",
"code": "D016627",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.342.478.650"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Oxidopamine",
"alternateName": "Oxidopamine",
"url": "https://questionsmedicales.fr/mesh/D016627",
"about": {
"@type": "MedicalCondition",
"name": "Oxidopamine",
"code": {
"@type": "MedicalCode",
"code": "D016627",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.342.478.650"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Épinéphrine",
"alternateName": "Epinephrine",
"url": "https://questionsmedicales.fr/mesh/D004837",
"about": {
"@type": "MedicalCondition",
"name": "Épinéphrine",
"code": {
"@type": "MedicalCode",
"code": "D004837",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.461"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Désoxyadrénaline",
"alternateName": "Deoxyepinephrine",
"url": "https://questionsmedicales.fr/mesh/D003846",
"about": {
"@type": "MedicalCondition",
"name": "Désoxyadrénaline",
"code": {
"@type": "MedicalCode",
"code": "D003846",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.461.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Métanéphrine",
"alternateName": "Metanephrine",
"url": "https://questionsmedicales.fr/mesh/D008676",
"about": {
"@type": "MedicalCondition",
"name": "Métanéphrine",
"code": {
"@type": "MedicalCode",
"code": "D008676",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.461.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Racépinéfrine",
"alternateName": "Racepinephrine",
"url": "https://questionsmedicales.fr/mesh/D064705",
"about": {
"@type": "MedicalCondition",
"name": "Racépinéfrine",
"code": {
"@type": "MedicalCode",
"code": "D064705",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.461.825"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Isoprénaline",
"alternateName": "Isoproterenol",
"url": "https://questionsmedicales.fr/mesh/D007545",
"about": {
"@type": "MedicalCondition",
"name": "Isoprénaline",
"code": {
"@type": "MedicalCode",
"code": "D007545",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.649"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Orciprénaline",
"alternateName": "Metaproterenol",
"url": "https://questionsmedicales.fr/mesh/D009921",
"about": {
"@type": "MedicalCondition",
"name": "Orciprénaline",
"code": {
"@type": "MedicalCode",
"code": "D009921",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.660"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fénotérol",
"alternateName": "Fenoterol",
"url": "https://questionsmedicales.fr/mesh/D005280",
"about": {
"@type": "MedicalCondition",
"name": "Fénotérol",
"code": {
"@type": "MedicalCode",
"code": "D005280",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.660.300"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Norépinéphrine",
"alternateName": "Norepinephrine",
"url": "https://questionsmedicales.fr/mesh/D009638",
"about": {
"@type": "MedicalCondition",
"name": "Norépinéphrine",
"code": {
"@type": "MedicalCode",
"code": "D009638",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.830"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "alpha-Méthyl-noradrénaline",
"alternateName": "Nordefrin",
"url": "https://questionsmedicales.fr/mesh/D008771",
"about": {
"@type": "MedicalCondition",
"name": "alpha-Méthyl-noradrénaline",
"code": {
"@type": "MedicalCode",
"code": "D008771",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.830.400"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Catécholamines",
"alternateName": "Catecholamines",
"code": {
"@type": "MedicalCode",
"code": "D002395",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Li Li",
"url": "https://questionsmedicales.fr/author/Li%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195, USA; Center for Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA 98195, USA; Seattle Children's Research Institute, Seattle, WA 98101, USA. Electronic address: lili1@uw.edu."
}
},
{
"@type": "Person",
"name": "Esther M Li",
"url": "https://questionsmedicales.fr/author/Esther%20M%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195, USA; Center for Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA 98195, USA; Department of Psychology, University of Washington, Seattle, WA 98105, USA."
}
},
{
"@type": "Person",
"name": "Jiesi Feng",
"url": "https://questionsmedicales.fr/author/Jiesi%20Feng",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Membrane Biology, School of Life Sciences, Peking University, Beijing 100871, China."
}
},
{
"@type": "Person",
"name": "Yulong Li",
"url": "https://questionsmedicales.fr/author/Yulong%20Li",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Membrane Biology, School of Life Sciences, Peking University, Beijing 100871, China; PKU-IDG/McGovern Institute for Brain Research, Beijing 100871, China; Peking-Tsinghua Center for Life Sciences, New Cornerstone Science Laboratory, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China."
}
},
{
"@type": "Person",
"name": "Michael R Bruchas",
"url": "https://questionsmedicales.fr/author/Michael%20R%20Bruchas",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195, USA; Center for Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA 98195, USA; Department of Bioengineering, University of Washington, Seattle, WA 98105, USA; Department of Pharmacology, University of Washington, Seattle, WA 98195, USA. Electronic address: mbruchas@uw.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Characteristics of deceleration capacity and deceleration runs in vasovagal syncope.",
"datePublished": "2023-09-30",
"url": "https://questionsmedicales.fr/article/37776375",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10286-023-00989-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Using a penalized likelihood to detect mortality deceleration.",
"datePublished": "2023-11-16",
"url": "https://questionsmedicales.fr/article/37972099",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0294428"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intrapartum deceleration and acceleration areas are associated with neonatal encephalopathy.",
"datePublished": "2023-01-09",
"url": "https://questionsmedicales.fr/article/36572017",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ijgo.14638"
}
},
{
"@type": "ScholarlyArticle",
"name": "Plasma myoglobin indicates muscle damage associated with acceleration/deceleration during football.",
"datePublished": "2023-09-15",
"url": "https://questionsmedicales.fr/article/37712927",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23736/S0022-4707.23.15203-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "The association of intrapartum deceleration and acceleration areas with MRI findings in neonatal encephalopathy.",
"datePublished": "2023-03-24",
"url": "https://questionsmedicales.fr/article/36964444",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41390-023-02575-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Phénols",
"item": "https://questionsmedicales.fr/mesh/D010636"
},
{
"@type": "ListItem",
"position": 8,
"name": "Catéchols",
"item": "https://questionsmedicales.fr/mesh/D002396"
},
{
"@type": "ListItem",
"position": 9,
"name": "Catécholamines",
"item": "https://questionsmedicales.fr/mesh/D002395"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Catécholamines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Catécholamines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Catécholamines",
"description": "Comment diagnostiquer un excès de catécholamines ?\nQuels tests sont utilisés pour mesurer les catécholamines ?\nQuels symptômes indiquent un déséquilibre des catécholamines ?\nQuelle imagerie peut aider au diagnostic ?\nLes tests génétiques sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D002395?mesh_terms=Deceleration#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Catécholamines",
"description": "Quels sont les symptômes d'un excès de catécholamines ?\nComment les catécholamines affectent-elles le cœur ?\nPeut-on ressentir des maux de tête ?\nLes troubles de l'humeur sont-ils liés ?\nY a-t-il des symptômes digestifs associés ?",
"url": "https://questionsmedicales.fr/mesh/D002395?mesh_terms=Deceleration#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Catécholamines",
"description": "Peut-on prévenir les troubles liés aux catécholamines ?\nQuels changements de mode de vie sont recommandés ?\nLe stress peut-il être évité ?\nLes examens réguliers sont-ils importants ?\nL'éducation sur les symptômes est-elle utile ?",
"url": "https://questionsmedicales.fr/mesh/D002395?mesh_terms=Deceleration#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Catécholamines",
"description": "Comment traiter un excès de catécholamines ?\nQuels médicaments sont utilisés ?\nLa chirurgie est-elle toujours nécessaire ?\nY a-t-il des traitements alternatifs ?\nComment surveiller l'efficacité du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D002395?mesh_terms=Deceleration#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Catécholamines",
"description": "Quelles complications peuvent survenir ?\nLes catécholamines peuvent-elles causer des AVC ?\nY a-t-il un risque de diabète ?\nLes troubles psychologiques sont-ils possibles ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D002395?mesh_terms=Deceleration#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Catécholamines",
"description": "Quels sont les principaux facteurs de risque ?\nLe mode de vie influence-t-il les risques ?\nLe tabagisme est-il un facteur de risque ?\nLe stress émotionnel joue-t-il un rôle ?\nLes maladies endocriniennes sont-elles un risque ?",
"url": "https://questionsmedicales.fr/mesh/D002395?mesh_terms=Deceleration#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un excès de catécholamines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un dosage sanguin ou urinaire des catécholamines peut confirmer l'excès."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer les catécholamines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sanguins et urinaires sont couramment utilisés pour mesurer les niveaux."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un déséquilibre des catécholamines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes comme hypertension, palpitations et anxiété peuvent indiquer un déséquilibre."
}
},
{
"@type": "Question",
"name": "Quelle imagerie peut aider au diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une IRM ou un scanner peut être utilisé pour détecter des tumeurs surrénaliennes."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aider à identifier des syndromes héréditaires liés aux catécholamines."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un excès de catécholamines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent hypertension, anxiété, palpitations et sueurs excessives."
}
},
{
"@type": "Question",
"name": "Comment les catécholamines affectent-elles le cœur ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer des palpitations et une augmentation de la fréquence cardiaque."
}
},
{
"@type": "Question",
"name": "Peut-on ressentir des maux de tête ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maux de tête peuvent survenir en raison de l'hypertension causée par les catécholamines."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur sont-ils liés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété et l'irritabilité peuvent être exacerbées par un excès de catécholamines."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes digestifs associés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées et des troubles gastro-intestinaux peuvent également se manifester."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux catécholamines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une gestion du stress et un mode de vie sain peuvent réduire les risques."
}
},
{
"@type": "Question",
"name": "Quels changements de mode de vie sont recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter une alimentation équilibrée, faire de l'exercice et éviter le tabac sont conseillés."
}
},
{
"@type": "Question",
"name": "Le stress peut-il être évité ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est difficile d'éliminer le stress, mais des techniques de relaxation peuvent aider."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans de santé réguliers peuvent aider à détecter des problèmes précocement."
}
},
{
"@type": "Question",
"name": "L'éducation sur les symptômes est-elle utile ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, connaître les symptômes permet une détection et une intervention précoces."
}
},
{
"@type": "Question",
"name": "Comment traiter un excès de catécholamines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des médicaments antihypertenseurs et une chirurgie si nécessaire."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bêta-bloquants et les inhibiteurs de la monoamine oxydase sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours nécessaire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est réservée aux cas de tumeurs surrénaliennes ou de phéochromocytomes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches comme la méditation peuvent aider à gérer le stress et les symptômes."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suivis réguliers des niveaux de catécholamines et de la pression artérielle sont essentiels."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'hypertension sévère et les maladies cardiaques peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les catécholamines peuvent-elles causer des AVC ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hypertension prolongée due aux catécholamines augmente le risque d'AVC."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de diabète ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un excès de catécholamines peut affecter la régulation de la glycémie, augmentant le risque de diabète."
}
},
{
"@type": "Question",
"name": "Les troubles psychologiques sont-ils possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété et la dépression peuvent être exacerbées par un déséquilibre des catécholamines."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un traitement approprié sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, le stress chronique et certaines tumeurs surrénaliennes sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il les risques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent les risques."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut exacerber les effets des catécholamines sur le système cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Le stress émotionnel joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress émotionnel chronique peut augmenter la production de catécholamines."
}
},
{
"@type": "Question",
"name": "Les maladies endocriniennes sont-elles un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies endocriniennes peuvent influencer la production de catécholamines."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 11/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195, USA; Center for Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA 98195, USA; Seattle Children's Research Institute, Seattle, WA 98101, USA. Electronic address: lili1@uw.edu.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195, USA; Center for Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA 98195, USA; Department of Psychology, University of Washington, Seattle, WA 98105, USA.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Membrane Biology, School of Life Sciences, Peking University, Beijing 100871, China.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Membrane Biology, School of Life Sciences, Peking University, Beijing 100871, China; PKU-IDG/McGovern Institute for Brain Research, Beijing 100871, China; Peking-Tsinghua Center for Life Sciences, New Cornerstone Science Laboratory, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195, USA; Center for Neurobiology of Addiction, Pain, and Emotion, University of Washington, Seattle, WA 98195, USA; Department of Bioengineering, University of Washington, Seattle, WA 98105, USA; Department of Pharmacology, University of Washington, Seattle, WA 98195, USA. Electronic address: mbruchas@uw.edu.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Emergency Medicine, Gunma University Graduate School of Medicine.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Emergency Medicine, Gunma University Graduate School of Medicine.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Emergency Medicine, Gunma University Graduate School of Medicine.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Emergency Medicine, Gunma University Graduate School of Medicine.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Emergency Medicine, Gunma University Graduate School of Medicine.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Autonomic Medicine Section, CNP/DIR/NINDS/NIH, Bethesda, Maryland (D.G., G.C., P.S.); NIH Academy Enrichment Program, OD/NIH (G.C.); and Sackler Faculty of Medicine, Tel Aviv University, Israel (Y.S.) goldsteind@ninds.nih.gov.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Autonomic Medicine Section, CNP/DIR/NINDS/NIH, Bethesda, Maryland (D.G., G.C., P.S.); NIH Academy Enrichment Program, OD/NIH (G.C.); and Sackler Faculty of Medicine, Tel Aviv University, Israel (Y.S.).
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Autonomic Medicine Section, CNP/DIR/NINDS/NIH, Bethesda, Maryland (D.G., G.C., P.S.); NIH Academy Enrichment Program, OD/NIH (G.C.); and Sackler Faculty of Medicine, Tel Aviv University, Israel (Y.S.).
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA. Electronic address: karel@mail.nih.gov.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
From the Department of Internal Medicine (C.D.C.C.v.d.H., L.G., S.T.K., M.P.N., S.K., A.H., L.A.B.J., H.J.L.M.T., M.G.N., N.P.R.), Radboud University Medical Center, Nijmegen, the Netherlands.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands; Department of Medicine, University Hospital Carl Gustav Carus at the TU Dresden, Dresden, Germany.
Publications dans "Catécholamines" :
2 publications dans cette catégorie
Affiliations :
Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center, Madrid, Spain.
Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
Publications dans "Catécholamines" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiovascular and Renal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Publications dans "Catécholamines" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiovascular and Renal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Publications dans "Catécholamines" :
Increased vagal activity plays a prominent role in vasovagal syncope (VVS). The aim of this study was to characterize vagal function in VVS by evaluating the heart rate (HR) deceleration capacity (DC)...
A total of 188 consecutive VVS patients were enrolled in the study, of whom 129 had positive head-up tilt test (HUTT); 132 healthy participants were enrolled as controls. DC, DRs (DR2, i.e., episodes ...
Patients with VVS had higher DC (10.63 ± 2.1 vs. 6.58 ± 1.7 ms; P < 0.001) and lower minimum HR and DR6-10 than controls. No significant differences in DC or DR6-10 were found between the patients wit...
Compared to healthy controls, patients with VVS demonstrated distinct HR deceleration profiles between attacks, including overall higher DC and lower DR6-10....
We suggest a novel method for detecting mortality deceleration by adding a penalty to the log-likelihood function in a gamma-Gompertz setting. This is an alternative to traditional likelihood inferenc...
To investigate whether an association exists between deceleration and acceleration areas on continuous fetal cardiotocography (CTG) and neonatal encephalopathy (NE)....
A single center, retrospective case-control study was conducted to compare CTG characteristics of low-risk pregnancies (35 weeks of gestation or more), complicated by moderate to severe NE with two ma...
During the period between 2013 and 2019, we identified 95 cases of low-risk pregnancies that were complicated by moderate to severe NE in our center. Thirty-three (34.7%) deliveries were excluded, mos...
NE was significantly associated with increased total deceleration area, decreased total acceleration area, and a lower acceleration-to-deceleration ratio, independent of cord blood pH. Development of ...
Monitoring muscle damage in athletes assists not only coaches to adjust the training workload but also medical staff to prevent injury. Measuring blood myoglobin concentration can help evaluate muscle...
Whole blood samples from participants' fingertips were collected before the match (baseline) and at 2, 16, and 40 h after the match. Myoglobin concentrations were measured using the IA-100 compact imm...
The mean myoglobin concentration was significantly higher at 2 h than at the other time points (P<0.05), and decreased to baseline levels within 16 h post-match. The mean creatine kinase concentration...
Our findings indicate that myoglobin is a more sensitive marker of muscle damage than creatine kinase after football match-play. Monitoring myoglobin in athletes can aid in determining their recovery ...
Hypoxic-ischemic encephalopathy (HIE) is an important contributor to disability worldwide. The current cardiotocography (CTG) predictive value for neonatal outcome is limited....
To assess the association of intrapartum CTG deceleration and acceleration areas with early MRI cerebral pathology in infants with HIE....
Term and near-term low-risk pregnancies that resulted in HIE, treated with therapeutic hypothermia with sufficient CTG records from a single, tertiary hospital between 2013 and 2021 were enrolled. Acc...
A total of 77 infants were included in the final analysis. Significant associations between increased total acceleration area (p = 0.007) and between a higher acceleration-to-deceleration area ratio (...
In neonates treated for HIE, acceleration area and acceleration-to-deceleration ratio are associated with the risk of neonatal brain MRI abnormalities. To increase the role of these measurements as a ...
The current cardiotocography predictive value for neonatal outcome is limited. This study aimed to assess the association of intrapartum deceleration and acceleration areas with the degree of cerebral...
The aim of this review is to summarize the current scientific knowledge about acceleration and deceleration demands during football training....
A systematic search of three electronic databases (PubMed, SPORTDiscus, Web of Science) was performed to identify peer-reviewed relevant English-language articles, following PRISMA guidelines....
All acceleration and deceleration data were analyzed and organized into four categories: i) training drills variables (i.e. manipulated drills variables such as number of players in small-sided games)...
Different exercises elicit different demands and small-sided games presented higher acceleration and deceleration demands than circuit training and other running based drills. Furthermore, manipulatin...
Modern societies provide an abundance of opportunities, which could lead to acceleration and time poverty, thereby paradoxically limiting well-being. This study examines this issue using social distan...
This study aimed to investigate the acute effects of lower limb wearable resistance on maximal horizontal deceleration biomechanics, across two different assessments. Twenty recreationally trained tea...
A new functional mapping strategy based on targeting deceleration zones (DZs) has become one of the most commonly used strategies within the armamentarium of substrate-based ablation methods for ventr...
The purpose of this study was to analyze the evolution of DZs during ablation and their correlation with CMR....
Forty-two consecutive patients with scar-related VT undergoing ablation after CMR in Hospital Clinic (October 2018-December 2020) were included (median age 65.3 ± 11.8 years; 94.7% male; 73.7% ischemi...
Overall, 95 DZs were analyzed, 93.68% of which were correlated with CMR-CCs: 44.8% located in the middle segment and 55.2% located in the entrance/exit of the channel. Remapping was performed in 91.7%...
DZs are highly correlated with CMR-CCs. In addition, remapping can lead to the identification of hidden substrate initially not identified by electroanatomic mapping but detected by CMR....
Deceleration is considered a commonly practised means to assess Foetal Heart Rate (FHR) through visual inspection and interpretation of patterns in Cardiotocography (CTG). The precision of deceleratio...